Biotechnology
The Biotechnology industry has a total of 612 stocks, with a combined market cap of $1.07 trillion and total revenue of $105.59 billion.
Market Cap
1.07T
Revenue
105.59B
Profits
-42.94B
PE Ratio
n/a
Profit Margin
-40.66%
Dividend Yield
0.04%
612 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 106.82B | -3.33% | 1,545,529 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 72.10B | -3.11% | 1,383,591 | 14.25B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 60.87B | -0.33% | 893,894 | 3.21B |
| 4 | ARGX | argenx SE | 56.30B | -0.43% | 324,361 | 3.68B |
| 5 | INSM | Insmed Incorporated | 43.41B | 0.96% | 1,581,719 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 39.15B | -2.78% | 234,756 | 5.00B |
| 7 | BNTX | BioNTech SE | 24.39B | -1.07% | 594,667 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 22.31B | -2.05% | 3,803,753 | 2.35B |
| 9 | INCY | Incyte Corporation | 19.89B | -2.47% | 2,734,795 | 4.81B |
| 10 | GMAB | Genmab A/S | 18.82B | 0.82% | 1,122,102 | 3.85B |
| 11 | ROIV | Roivant Sciences Ltd. | 14.15B | -0.88% | 6,930,642 | 20.33M |
| 12 | RVMD | Revolution Medicines, Inc. | 13.63B | -0.07% | 2,010,250 | - |
| 13 | ASND | Ascendis Pharma A/S | 12.96B | -2.29% | 542,244 | 758.59M |
| 14 | BBIO | BridgeBio Pharma, Inc. | 12.63B | -0.08% | 1,270,385 | 353.78M |
| 15 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.62B | -0.61% | 237,464 | 740.64M |
| 16 | SMMT | Summit Therapeutics Inc. | 12.33B | -1.49% | 1,936,714 | - |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 11.99B | -0.67% | 3,620,815 | 966.96M |
| 18 | EXEL | Exelixis, Inc. | 11.34B | -1.20% | 2,195,362 | 2.29B |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 10.70B | -2.46% | 1,840,725 | 4.16B |
| 20 | RNA | Avidity Biosciences, Inc. | 10.68B | 0.06% | 2,895,454 | 20.87M |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.10B | -2.95% | 2,057,453 | 3.09B |
| 22 | MRNA | Moderna, Inc. | 9.45B | -2.97% | 9,400,507 | 2.23B |
| 23 | TECH | Bio-Techne Corporation | 9.01B | -0.58% | 1,257,133 | 1.22B |
| 24 | ABVX | ABIVAX Société Anonyme | 8.44B | -0.77% | 797,509 | 7.07M |
| 25 | HALO | Halozyme Therapeutics, Inc. | 8.26B | 0.21% | 1,737,861 | 1.24B |
| 26 | CORT | Corcept Therapeutics Incorporated | 8.00B | 1.32% | 433,148 | 741.17M |
| 27 | CYTK | Cytokinetics, Incorporated | 7.92B | -2.07% | 2,440,560 | 87.21M |
| 28 | NUVL | Nuvalent, Inc. | 7.79B | 2.77% | 2,169,460 | - |
| 29 | AXSM | Axsome Therapeutics, Inc. | 7.40B | -0.48% | 492,280 | 561.26M |
| 30 | MRUS | Merus N.V. | 7.28B | 0.25% | 1,844,411 | 56.61M |
| 31 | CDTX | Cidara Therapeutics, Inc. | 6.89B | 0.28% | 4,128,491 | 302.00K |
| 32 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.88B | 2.63% | 796,929 | 174.33M |
| 33 | CAI | Caris Life Sciences, Inc. | 6.74B | 0.59% | 1,750,016 | 649.06M |
| 34 | PCVX | Vaxcyte, Inc. | 6.37B | -1.82% | 1,848,000 | - |
| 35 | PTCT | PTC Therapeutics, Inc. | 6.07B | -1.42% | 1,022,906 | 1.78B |
| 36 | KRYS | Krystal Biotech, Inc. | 5.92B | -0.31% | 229,078 | 373.16M |
| 37 | ARWR | Arrowhead Pharmaceuticals, Inc. | 5.39B | -3.71% | 2,881,976 | 572.98M |
| 38 | PTGX | Protagonist Therapeutics, Inc. | 5.32B | 0.88% | 989,454 | 209.22M |
| 39 | COGT | Cogent Biosciences, Inc. | 5.32B | 4.61% | 3,816,825 | - |
| 40 | ACLX | Arcellx, Inc. | 5.18B | -0.41% | 1,052,193 | 35.90M |
| 41 | LEGN | Legend Biotech Corporation | 5.17B | -4.83% | 2,911,314 | 909.05M |
| 42 | CRSP | CRISPR Therapeutics AG | 4.83B | -5.12% | 1,736,906 | 38.34M |
| 43 | PRAX | Praxis Precision Medicines, Inc. | 4.73B | 2.82% | 853,577 | 7.46M |
| 44 | KYMR | Kymera Therapeutics, Inc. | 4.66B | 0.79% | 505,135 | 43.74M |
| 45 | AKRO | Akero Therapeutics, Inc. | 4.47B | 0.02% | 1,375,065 | - |
| 46 | TGTX | TG Therapeutics, Inc. | 4.43B | -2.82% | 1,903,286 | 531.90M |
| 47 | NAMS | NewAmsterdam Pharma Company N.V. | 4.38B | -0.75% | 994,421 | 35.24M |
| 48 | CELC | Celcuity Inc. | 4.36B | 2.87% | 751,552 | - |
| 49 | APGE | Apogee Therapeutics, Inc. | 4.31B | -0.13% | 486,024 | - |
| 50 | BLTE | Belite Bio, Inc | 4.20B | -2.29% | 59,259 | - |
| 51 | CNTA | Centessa Pharmaceuticals plc | 4.09B | -1.27% | 1,477,348 | 15.00M |
| 52 | VKTX | Viking Therapeutics, Inc. | 4.07B | -4.56% | 4,622,687 | - |
| 53 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.07B | -0.26% | 1,516,159 | 1.54M |
| 54 | IMVT | Immunovant, Inc. | 4.06B | -2.24% | 908,993 | - |
| 55 | SRRK | Scholar Rock Holding Corporation | 4.05B | -0.30% | 2,713,877 | - |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 3.91B | -2.94% | 1,449,537 | 1.05B |
| 57 | ADMA | ADMA Biologics, Inc. | 3.80B | 1.66% | 2,772,544 | 488.56M |
| 58 | MIRM | Mirum Pharmaceuticals, Inc. | 3.62B | -2.43% | 591,044 | 471.79M |
| 59 | CGON | CG Oncology, Inc. | 3.44B | 0.12% | 620,582 | 2.17M |
| 60 | IRON | Disc Medicine, Inc. | 3.43B | 1.11% | 676,851 | - |
| 61 | ARQT | Arcutis Biotherapeutics, Inc. | 3.42B | 2.24% | 3,459,284 | 317.93M |
| 62 | MLYS | Mineralys Therapeutics, Inc. | 3.33B | -2.93% | 1,550,729 | - |
| 63 | TARS | Tarsus Pharmaceuticals, Inc. | 3.27B | 0.18% | 355,021 | 366.10M |
| 64 | TVTX | Travere Therapeutics, Inc. | 3.17B | -1.58% | 1,258,419 | 435.83M |
| 65 | XENE | Xenon Pharmaceuticals Inc. | 3.14B | 0.10% | 559,167 | 7.50M |
| 66 | RARE | Ultragenyx Pharmaceutical Inc. | 3.07B | -2.95% | 1,068,056 | 630.60M |
| 67 | TLX | Telix Pharmaceuticals Limited | 3.05B | -1.53% | 61,899 | 664.23M |
| 68 | FOLD | Amicus Therapeutics, Inc. | 3.00B | 1.46% | 4,067,557 | 598.70M |
| 69 | AAPG | Ascentage Pharma Group International | 2.99B | 0.63% | 1,294 | 54.52M |
| 70 | DYN | Dyne Therapeutics, Inc. | 2.94B | -1.72% | 1,991,580 | - |
| 71 | IDYA | IDEAYA Biosciences, Inc. | 2.90B | -1.72% | 925,243 | 214.83M |
| 72 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.77B | -0.66% | 1,215,142 | 578.20M |
| 73 | VRDN | Viridian Therapeutics, Inc. | 2.74B | 0.31% | 1,152,142 | 70.79M |
| 74 | LQDA | Liquidia Corporation | 2.58B | -1.85% | 2,218,335 | 69.22M |
| 75 | OCUL | Ocular Therapeutix, Inc. | 2.58B | 2.89% | 2,842,411 | 55.78M |
| 76 | SLNO | Soleno Therapeutics, Inc. | 2.52B | -3.17% | 1,352,516 | 98.68M |
| 77 | DNLI | Denali Therapeutics Inc. | 2.48B | -3.20% | 1,623,988 | - |
| 78 | APLS | Apellis Pharmaceuticals, Inc. | 2.46B | -1.42% | 1,997,642 | 1.02B |
| 79 | NUVB | Nuvation Bio Inc. | 2.45B | 48.96% | 59,110,306 | 26.75M |
| 80 | TERN | Terns Pharmaceuticals, Inc. | 2.44B | -1.60% | 4,201,716 | - |
| 81 | EWTX | Edgewise Therapeutics, Inc. | 2.37B | 0.81% | 1,182,209 | - |
| 82 | ADPT | Adaptive Biotechnologies Corporation | 2.31B | 10.18% | 2,813,380 | 252.75M |
| 83 | ZLAB | Zai Lab Limited | 2.27B | 0.10% | 517,563 | 441.63M |
| 84 | GPCR | Structure Therapeutics Inc. | 2.22B | 5.83% | 3,278,544 | - |
| 85 | RCUS | Arcus Biosciences, Inc. | 2.18B | 0.15% | 1,141,256 | 240.00M |
| 86 | IBRX | ImmunityBio, Inc. | 2.11B | 1.90% | 7,748,333 | 82.56M |
| 87 | RXRX | Recursion Pharmaceuticals, Inc. | 2.10B | -3.12% | 27,831,253 | 43.69M |
| 88 | BEAM | Beam Therapeutics Inc. | 2.07B | -4.29% | 1,652,641 | 55.70M |
| 89 | GLPG | Galapagos NV | 2.01B | 0.23% | 143,303 | 336.64M |
| 90 | AUPH | Aurinia Pharmaceuticals Inc. | 2.00B | -1.94% | 2,286,613 | 265.81M |
| 91 | ZBIO | Zenas BioPharma, Inc. | 1.99B | 2.60% | 255,947 | 15.00M |
| 92 | VCEL | Vericel Corporation | 1.97B | -0.20% | 447,347 | 258.72M |
| 93 | IMCR | Immunocore Holdings plc | 1.95B | 1.55% | 354,548 | 379.59M |
| 94 | HRMY | Harmony Biosciences Holdings, Inc. | 1.92B | -2.00% | 926,542 | 825.94M |
| 95 | MESO | Mesoblast Limited | 1.91B | -0.27% | 76,185 | 17.20M |
| 96 | SYRE | Spyre Therapeutics, Inc. | 1.89B | 0.83% | 586,745 | - |
| 97 | VERA | Vera Therapeutics, Inc. | 1.83B | -1.25% | 1,227,020 | - |
| 98 | PHVS | Pharvaris N.V. | 1.77B | 2.38% | 703,626 | - |
| 99 | DNTH | Dianthus Therapeutics, Inc. | 1.75B | -0.07% | 1,839,188 | 3.08M |
| 100 | QURE | uniQure N.V. | 1.74B | -5.92% | 2,030,387 | 15.75M |
| 101 | JANX | Janux Therapeutics, Inc. | 1.73B | -0.72% | 700,932 | 10.00M |
| 102 | SRPT | Sarepta Therapeutics, Inc. | 1.72B | -6.02% | 4,398,183 | 2.41B |
| 103 | SION | Sionna Therapeutics, Inc. | 1.71B | -1.81% | 255,628 | - |
| 104 | MAZE | Maze Therapeutics, Inc. | 1.71B | 6.95% | 679,398 | 2.50M |
| 105 | ZYME | Zymeworks Inc. | 1.69B | -1.70% | 1,938,163 | 134.48M |
| 106 | CLDX | Celldex Therapeutics, Inc. | 1.66B | -2.58% | 893,460 | 2.60M |
| 107 | STOK | Stoke Therapeutics, Inc. | 1.63B | -1.52% | 557,422 | 205.63M |
| 108 | IMNM | Immunome, Inc. | 1.62B | -0.95% | 1,450,506 | 9.68M |
| 109 | INVA | Innoviva, Inc. | 1.59B | -2.74% | 829,999 | 388.52M |
| 110 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.57B | 2.65% | 1,481,343 | -665.00K |
| 111 | MNKD | MannKind Corporation | 1.54B | -1.19% | 2,731,105 | 313.79M |
| 112 | PGEN | Precigen, Inc. | 1.49B | -12.99% | 5,266,571 | 6.31M |
| 113 | NRIX | Nurix Therapeutics, Inc. | 1.45B | 13.01% | 1,676,702 | 83.69M |
| 114 | SNDX | Syndax Pharmaceuticals, Inc. | 1.45B | -2.22% | 1,940,617 | 111.30M |
| 115 | TRVI | Trevi Therapeutics, Inc. | 1.42B | -2.39% | 1,899,450 | - |
| 116 | ORKA | Oruka Therapeutics, Inc. | 1.37B | 2.95% | 380,974 | - |
| 117 | ARDX | Ardelyx, Inc. | 1.35B | -4.13% | 3,286,927 | 398.23M |
| 118 | UPB | Upstream Bio, Inc. | 1.35B | -2.43% | 422,235 | 2.80M |
| 119 | OLMA | Olema Pharmaceuticals, Inc. | 1.33B | -3.53% | 18,827,900 | - |
| 120 | ELVN | Enliven Therapeutics, Inc. | 1.31B | -2.17% | 440,423 | - |
| 121 | AGIO | Agios Pharmaceuticals, Inc. | 1.30B | -50.89% | 17,657,457 | 44.79M |
| 122 | RAPP | Rapport Therapeutics, Inc. | 1.28B | 6.16% | 263,557 | - |
| 123 | IMTX | Immatics N.V. | 1.26B | 0.10% | 597,745 | 99.45M |
| 124 | BHVN | Biohaven Ltd. | 1.26B | 0.11% | 3,918,818 | - |
| 125 | MBX | MBX Biosciences, Inc. | 1.23B | 3.91% | 655,779 | - |
| 126 | NKTR | Nektar Therapeutics | 1.23B | 1.99% | 636,248 | 62.60M |
| 127 | INBX | Inhibrx Biosciences, Inc. | 1.19B | 5.86% | 409,768 | 1.40M |
| 128 | URGN | UroGen Pharma Ltd. | 1.18B | 7.30% | 2,384,377 | 96.52M |
| 129 | EYPT | EyePoint Pharmaceuticals, Inc. | 1.18B | 2.29% | 1,402,789 | 42.34M |
| 130 | XERS | Xeris Biopharma Holdings, Inc. | 1.18B | 0.14% | 1,748,686 | 266.14M |
| 131 | CVAC | CureVac N.V. | 1.18B | -0.19% | 727,445 | 599.54M |
| 132 | WVE | Wave Life Sciences Ltd. | 1.15B | -3.23% | 2,146,958 | 109.23M |
| 133 | PVLA | Palvella Therapeutics, Inc. | 1.15B | 16.84% | 596,927 | - |
| 134 | XNCR | Xencor, Inc. | 1.13B | -1.56% | 666,205 | 150.13M |
| 135 | ORIC | ORIC Pharmaceuticals, Inc. | 1.12B | -3.53% | 657,698 | - |
| 136 | TNGX | Tango Therapeutics, Inc. | 1.12B | 3.56% | 5,343,747 | 66.50M |
| 137 | SVRA | Savara Inc. | 1.11B | 10.31% | 3,490,050 | - |
| 138 | RLAY | Relay Therapeutics, Inc. | 1.10B | -2.61% | 2,025,573 | 8.36M |
| 139 | TSHA | Taysha Gene Therapies, Inc. | 1.10B | -3.37% | 2,350,421 | 6.31M |
| 140 | PHAR | Pharming Group N.V. | 1.10B | 1.26% | 29,208 | 362.27M |
| 141 | ABCL | AbCellera Biologics Inc. | 1.08B | -1.37% | 2,809,900 | 35.33M |
| 142 | MNMD | Mind Medicine (MindMed) Inc. | 1.08B | -4.21% | 1,244,815 | - |
| 143 | SEPN | Septerna, Inc. | 1.03B | 6.50% | 390,471 | 22.05M |
| 144 | KOD | Kodiak Sciences Inc. | 1.03B | 1.61% | 588,447 | - |
| 145 | NVAX | Novavax, Inc. | 1.03B | -3.50% | 6,686,421 | 1.06B |
| 146 | NBTX | Nanobiotix S.A. | 1.03B | -0.64% | 71,717 | 11.93M |
| 147 | PHAT | Phathom Pharmaceuticals, Inc. | 1.03B | -1.40% | 718,697 | 147.19M |
| 148 | ANAB | AnaptysBio, Inc. | 1.02B | - | 353,105 | 169.47M |
| 149 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 1.01B | -5.93% | 131,174 | - |
| 150 | OCS | Oculis Holding AG | 1.01B | -0.08% | 112,606 | 992.00K |
| 151 | KURA | Kura Oncology, Inc. | 985.04M | 2.17% | 1,633,479 | 104.03M |
| 152 | MLTX | MoonLake Immunotherapeutics | 966.40M | 1.04% | 1,478,674 | - |
| 153 | MDXG | MiMedx Group, Inc. | 959.70M | -3.57% | 912,297 | 393.44M |
| 154 | NTLA | Intellia Therapeutics, Inc. | 954.44M | -2.72% | 4,012,256 | 57.53M |
| 155 | RZLT | Rezolute, Inc. | 942.11M | - | 2,074,574 | - |
| 156 | FTRE | Fortrea Holdings Inc. | 927.70M | -1.57% | 896,073 | 2.76B |
| 157 | GLUE | Monte Rosa Therapeutics, Inc. | 920.77M | 2.61% | 524,650 | 181.54M |
| 158 | SANA | Sana Biotechnology, Inc. | 905.64M | -3.68% | 2,557,655 | - |
| 159 | TBPH | Theravance Biopharma, Inc. | 898.42M | -4.11% | 538,229 | 80.33M |
| 160 | IOVA | Iovance Biotherapeutics, Inc. | 897.15M | -7.38% | 9,940,215 | 250.43M |
| 161 | MRVI | Maravai LifeSciences Holdings, Inc. | 894.97M | -3.31% | 874,667 | 192.44M |
| 162 | GHRS | GH Research PLC | 891.98M | 4.58% | 403,415 | - |
| 163 | LENZ | LENZ Therapeutics, Inc. | 888.64M | 4.30% | 1,203,812 | 17.50M |
| 164 | TYRA | Tyra Biosciences, Inc. | 887.04M | 3.62% | 264,005 | - |
| 165 | CMPX | Compass Therapeutics, Inc. | 871.52M | -0.61% | 1,091,798 | 850.00K |
| 166 | DAWN | Day One Biopharmaceuticals, Inc. | 863.50M | -1.87% | 2,213,807 | 133.67M |
| 167 | BCAX | Bicara Therapeutics Inc. | 831.59M | -2.50% | 577,719 | - |
| 168 | AVBP | ArriVent BioPharma, Inc. | 826.87M | -0.89% | 136,261 | - |
| 169 | ABUS | Arbutus Biopharma Corporation | 821.22M | -4.04% | 2,842,981 | 14.61M |
| 170 | ATAI | Atai Beckley N.V. | 818.77M | -2.80% | 3,360,389 | 3.02M |
| 171 | CRMD | CorMedix Inc. | 790.25M | -0.50% | 2,138,887 | 214.30M |
| 172 | RAPT | RAPT Therapeutics, Inc. | 785.33M | 0.21% | 281,487 | - |
| 173 | ERAS | Erasca, Inc. | 783.04M | -3.50% | 2,042,761 | - |
| 174 | VIR | Vir Biotechnology, Inc. | 756.84M | -1.09% | 1,571,477 | 16.86M |
| 175 | RIGL | Rigel Pharmaceuticals, Inc. | 756.55M | -9.82% | 1,002,193 | 282.08M |
| 176 | ARVN | Arvinas, Inc. | 740.51M | -11.24% | 3,701,226 | 312.30M |
| 177 | VALN | Valneva SE | 740.18M | -0.58% | 8,931 | 230.57M |
| 178 | GOSS | Gossamer Bio, Inc. | 726.77M | 2.95% | 3,055,145 | 44.05M |
| 179 | VSTM | Verastem, Inc. | 715.48M | - | 2,298,381 | 13.38M |
| 180 | ATXS | Astria Therapeutics, Inc. | 710.14M | -0.40% | 497,923 | 706.00K |
| 181 | REPL | Replimune Group, Inc. | 705.21M | 2.86% | 1,896,364 | - |
| 182 | SPRY | ARS Pharmaceuticals, Inc. | 700.84M | - | 2,513,567 | 142.77M |
| 183 | PROK | ProKidney Corp. | 697.94M | 1.75% | 1,195,297 | 744.00K |
| 184 | KALV | KalVista Pharmaceuticals, Inc. | 692.99M | -3.92% | 1,523,844 | 1.43M |
| 185 | GERN | Geron Corporation | 689.42M | -2.70% | 7,983,042 | 183.40M |
| 186 | GYRE | Gyre Therapeutics, Inc. | 688.04M | -1.30% | 41,648 | 107.27M |
| 187 | ALMS | Alumis Inc. | 685.86M | 2.50% | 1,620,677 | 22.12M |
| 188 | VTYX | Ventyx Biosciences, Inc. | 675.77M | -2.77% | 1,203,231 | - |
| 189 | CRVS | Corvus Pharmaceuticals, Inc. | 664.67M | -2.09% | 742,780 | - |
| 190 | LXEO | Lexeo Therapeutics, Inc. | 663.45M | -0.98% | 1,708,598 | - |
| 191 | PRME | Prime Medicine, Inc. | 658.58M | 4.79% | 5,560,004 | 5.98M |
| 192 | YDES | YD Bio Limited | 653.97M | -4.81% | 44,644 | 510.36K |
| 193 | MPLT | MapLight Therapeutics, Inc. | 632.80M | -2.49% | 212,039 | - |
| 194 | FULC | Fulcrum Therapeutics, Inc. | 622.90M | 18.29% | 3,862,363 | 80.00M |
| 195 | FDMT | 4D Molecular Therapeutics, Inc. | 617.06M | 7.04% | 905,164 | 120.00K |
| 196 | CTMX | CytomX Therapeutics, Inc. | 615.05M | -0.82% | 1,664,636 | 113.63M |
| 197 | MGTX | MeiraGTx Holdings plc | 610.12M | -2.19% | 516,306 | 27.42M |
| 198 | ASMB | Assembly Biosciences, Inc. | 601.05M | 5.88% | 270,065 | 37.19M |
| 199 | ANNX | Annexon, Inc. | 587.60M | 26.87% | 10,643,716 | - |
| 200 | IVVD | Invivyd, Inc. | 582.81M | -1.19% | 6,471,872 | 50.04M |
| 201 | OMER | Omeros Corporation | 582.80M | -3.29% | 1,362,396 | - |
| 202 | EVMN | Evommune, Inc. | 580.20M | -4.46% | 48,006 | 3.00M |
| 203 | JBIO | Jade Biosciences, Inc. | 573.21M | -1.50% | 185,979 | - |
| 204 | IVA | Inventiva S.A. | 555.45M | -1.20% | 186,491 | 19.93M |
| 205 | MNPR | Monopar Therapeutics Inc. | 554.65M | 2.98% | 121,635 | - |
| 206 | RGNX | REGENXBIO Inc. | 553.31M | -2.84% | 585,786 | 161.32M |
| 207 | NAGE | Niagen Bioscience, Inc. | 552.62M | 0.58% | 829,165 | 124.71M |
| 208 | ZVRA | Zevra Therapeutics, Inc. | 544.96M | -0.21% | 981,035 | 84.39M |
| 209 | PRTA | Prothena Corporation plc | 537.76M | -3.57% | 479,680 | 11.79M |
| 210 | LXRX | Lexicon Pharmaceuticals, Inc. | 526.93M | -1.36% | 1,604,064 | 70.86M |
| 211 | NBP | NovaBridge Biosciences | 522.16M | -0.22% | 403,618 | - |
| 212 | KROS | Keros Therapeutics, Inc. | 513.66M | -3.93% | 1,435,459 | 246.72M |
| 213 | CGEM | Cullinan Therapeutics, Inc. | 499.19M | -1.05% | 836,120 | - |
| 214 | ADCT | ADC Therapeutics SA | 497.99M | 0.50% | 636,872 | 75.21M |
| 215 | DBVT | DBV Technologies S.A. | 485.34M | 2.26% | 42,242 | 5.50M |
| 216 | ANRO | Alto Neuroscience, Inc. | 482.77M | 5.36% | 518,574 | - |
| 217 | ALT | Altimmune, Inc. | 478.93M | -1.29% | 4,025,390 | 20.00K |
| 218 | OPT | Opthea Limited | 466.57M | 7.23% | 3,025 | 146.00K |
| 219 | IMRX | Immuneering Corporation | 462.97M | 0.28% | 777,722 | - |
| 220 | DRUG | Bright Minds Biosciences Inc. | 454.54M | 0.97% | 118,692 | - |
| 221 | DNA | Ginkgo Bioworks Holdings, Inc. | 449.57M | 1.02% | 1,034,830 | 180.61M |
| 222 | BNTC | Benitec Biopharma Inc. | 443.93M | -3.10% | 187,846 | - |
| 223 | ENGN | enGene Holdings Inc. | 436.55M | -1.74% | 1,749,729 | - |
| 224 | BCYC | Bicycle Therapeutics plc | 433.55M | -3.40% | 379,529 | 28.34M |
| 225 | ABSI | Absci Corporation | 430.06M | 0.70% | 3,432,490 | 2.82M |
| 226 | NMRA | Neumora Therapeutics, Inc. | 424.41M | -4.51% | 1,007,217 | - |
| 227 | DSGN | Design Therapeutics, Inc. | 418.11M | -3.29% | 223,334 | - |
| 228 | LCTX | Lineage Cell Therapeutics, Inc. | 414.38M | -3.39% | 1,137,307 | 10.82M |
| 229 | XOMA | XOMA Royalty Corporation | 410.50M | 1.10% | 90,713 | 47.11M |
| 230 | LBRX | LB Pharmaceuticals Inc | 401.62M | -0.28% | 95,647 | - |
| 231 | VTVT | vTv Therapeutics Inc. | 400.06M | 7.07% | 21,295 | 17.00K |
| 232 | PRTC | PureTech Health plc | 392.51M | 0.76% | 1,087 | 6.39M |
| 233 | PEPG | PepGen Inc. | 380.18M | -3.66% | 859,942 | - |
| 234 | DMAC | DiaMedica Therapeutics Inc. | 380.17M | 5.80% | 811,236 | - |
| 235 | GALT | Galectin Therapeutics Inc. | 370.11M | -7.27% | 263,143 | - |
| 236 | LYEL | Lyell Immunopharma, Inc. | 365.38M | -3.96% | 22,209 | 41.00K |
| 237 | CTNM | Contineum Therapeutics, Inc. | 362.74M | 7.99% | 135,060 | - |
| 238 | KYTX | Kyverna Therapeutics, Inc. | 360.44M | 5.11% | 748,516 | - |
| 239 | OCGN | Ocugen, Inc. | 356.04M | -0.87% | 2,259,772 | 5.37M |
| 240 | TECX | Tectonic Therapeutic, Inc. | 351.12M | 2.63% | 467,913 | - |
| 241 | SLDB | Solid Biosciences Inc. | 349.04M | 0.22% | 1,065,848 | - |
| 242 | AURA | Aura Biosciences, Inc. | 342.92M | -0.18% | 173,438 | - |
| 243 | ENTA | Enanta Pharmaceuticals, Inc. | 338.16M | -1.86% | 259,095 | 65.32M |
| 244 | AUTL | Autolus Therapeutics plc | 338.00M | -1.55% | 1,470,848 | 51.13M |
| 245 | FBRX | Forte Biosciences, Inc. | 333.65M | 4.12% | 267,696 | - |
| 246 | CLLS | Cellectis S.A. | 325.83M | 7.06% | 131,677 | 82.55M |
| 247 | NGNE | Neurogene Inc. | 325.13M | -1.73% | 130,515 | 925.00K |
| 248 | PALI | Palisade Bio, Inc. | 323.34M | 4.83% | 5,000,831 | - |
| 249 | XFOR | X4 Pharmaceuticals, Inc. | 319.14M | 1.39% | 575,439 | 33.98M |
| 250 | AVTX | Avalo Therapeutics, Inc. | 318.98M | -2.28% | 220,274 | 192.00K |
| 251 | EPRX | Eupraxia Pharmaceuticals Inc. | 316.96M | -2.67% | 62,555 | - |
| 252 | TRDA | Entrada Therapeutics, Inc. | 313.07M | -1.02% | 332,545 | 61.52M |
| 253 | DRTS | Alpha Tau Medical Ltd. | 312.96M | - | 20,566 | - |
| 254 | RCKT | Rocket Pharmaceuticals, Inc. | 311.68M | -2.04% | 3,079,834 | - |
| 255 | AVXL | Anavex Life Sciences Corp. | 309.22M | 2.86% | 2,212,395 | - |
| 256 | ACIU | AC Immune SA | 308.70M | 2.30% | 129,169 | 5.48M |
| 257 | RLMD | Relmada Therapeutics, Inc. | 306.53M | -2.11% | 2,464,062 | - |
| 258 | NAUT | Nautilus Biotechnology, Inc. | 304.40M | 9.05% | 886,912 | - |
| 259 | VNDA | Vanda Pharmaceuticals Inc. | 303.76M | -3.93% | 1,773,613 | 212.07M |
| 260 | SLN | Silence Therapeutics plc | 303.71M | -4.74% | 294,251 | 25.83M |
| 261 | LRMR | Larimar Therapeutics, Inc. | 297.00M | 2.36% | 2,613,787 | - |
| 262 | TENX | Tenax Therapeutics, Inc. | 296.97M | -4.81% | 34,529 | - |
| 263 | CYBN | Cybin Inc. | 295.93M | -1.50% | 807,265 | - |
| 264 | ALDX | Aldeyra Therapeutics, Inc. | 292.39M | -1.02% | 503,015 | - |
| 265 | MREO | Mereo BioPharma Group plc | 288.03M | -0.55% | 1,512,869 | 500.00K |
| 266 | PYXS | Pyxis Oncology, Inc. | 284.55M | -3.18% | 362,111 | 2.82M |
| 267 | ALLO | Allogene Therapeutics, Inc. | 283.16M | -3.82% | 2,212,946 | 22.00K |
| 268 | FENC | Fennec Pharmaceuticals Inc. | 279.38M | -6.51% | 144,558 | 38.79M |
| 269 | FHTX | Foghorn Therapeutics Inc. | 274.84M | -3.19% | 127,011 | 24.52M |
| 270 | ACRS | Aclaris Therapeutics, Inc. | 266.53M | -1.20% | 771,386 | 15.74M |
| 271 | ARMP | Armata Pharmaceuticals, Inc. | 265.21M | 6.10% | 69,449 | 5.05M |
| 272 | CAPR | Capricor Therapeutics, Inc. | 263.80M | 2.30% | 842,892 | 11.13M |
| 273 | OBIO | Orchestra BioMed Holdings, Inc. | 263.13M | 10.17% | 572,182 | 2.82M |
| 274 | MCRB | Seres Therapeutics, Inc. | 259.00M | 15.86% | 957,236 | 351.00K |
| 275 | TARA | Protara Therapeutics, Inc. | 258.92M | -0.59% | 1,483,052 | - |
| 276 | SGMT | Sagimet Biosciences Inc. | 255.29M | 0.38% | 315,878 | - |
| 277 | CBIO | Crescent Biopharma, Inc. | 254.73M | 0.23% | 39,282 | - |
| 278 | IMMP | Immutep Limited | 252.06M | -2.29% | 163,722 | 3.31M |
| 279 | ZURA | Zura Bio Limited | 251.64M | 1.04% | 440,813 | - |
| 280 | PBYI | Puma Biotechnology, Inc. | 246.16M | -3.46% | 307,111 | 212.00M |
| 281 | AVIR | Atea Pharmaceuticals, Inc. | 246.10M | 3.28% | 382,606 | - |
| 282 | EDIT | Editas Medicine, Inc. | 246.00M | -3.82% | 1,199,481 | 46.38M |
| 283 | CADL | Candel Therapeutics, Inc. | 242.65M | -4.33% | 518,700 | - |
| 284 | CCCC | C4 Therapeutics, Inc. | 242.29M | 0.81% | 1,102,486 | 30.11M |
| 285 | OABI | OmniAb, Inc. | 237.53M | 2.48% | 396,331 | 21.09M |
| 286 | MIST | Milestone Pharmaceuticals Inc. | 236.69M | -3.32% | 2,917,547 | - |
| 287 | VYGR | Voyager Therapeutics, Inc. | 231.30M | -2.80% | 405,603 | 31.32M |
| 288 | ACHV | Achieve Life Sciences, Inc. | 229.97M | -0.23% | 388,119 | - |
| 289 | MDWD | MediWound Ltd. | 228.99M | -2.30% | 97,416 | 19.86M |
| 290 | AARD | Aardvark Therapeutics, Inc. | 227.75M | 6.30% | 176,027 | - |
| 291 | ABEO | Abeona Therapeutics Inc. | 227.60M | -6.25% | 2,074,846 | 400.00K |
| 292 | GNFT | Genfit S.A. | 223.01M | 2.54% | 56,948 | 52.99M |
| 293 | BDTX | Black Diamond Therapeutics, Inc. | 221.63M | -2.02% | 682,291 | 70.00M |
| 294 | HUMA | Humacyte, Inc. | 219.11M | -2.50% | 4,707,455 | 1.57M |
| 295 | SLS | SELLAS Life Sciences Group, Inc. | 216.51M | -4.40% | 2,653,502 | - |
| 296 | CABA | Cabaletta Bio, Inc. | 215.63M | -4.27% | 1,830,497 | - |
| 297 | PRQR | ProQR Therapeutics N.V. | 213.85M | -2.40% | 146,414 | 18.86M |
| 298 | RANI | Rani Therapeutics Holdings, Inc. | 212.65M | -5.91% | 2,557,305 | 1.20M |
| 299 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 207.48M | -1.58% | 294,225 | - |
| 300 | TLSA | Tiziana Life Sciences Ltd | 200.81M | -4.52% | 102,139 | - |
| 301 | HRTX | Heron Therapeutics, Inc. | 199.87M | -2.68% | 4,098,457 | 155.10M |
| 302 | TNYA | Tenaya Therapeutics, Inc. | 198.14M | -7.03% | 2,037,200 | - |
| 303 | TNXP | Tonix Pharmaceuticals Holding Corp. | 196.90M | 2.51% | 1,587,806 | 10.30M |
| 304 | GNLX | Genelux Corporation | 188.09M | -1.19% | 135,048 | 8.00K |
| 305 | RNAC | Cartesian Therapeutics, Inc. | 185.93M | -6.17% | 101,809 | 1.09M |
| 306 | GUTS | Fractyl Health, Inc. | 182.27M | -5.00% | 1,681,749 | 3.00K |
| 307 | VTGN | Vistagen Therapeutics, Inc. | 177.73M | -2.81% | 724,883 | 721.00K |
| 308 | CNTB | Connect Biopharma Holdings Limited | 176.10M | 22.57% | 1,877,675 | 762.00K |
| 309 | ETHZ | ETHZilla Corporation | 175.30M | -11.93% | 1,319,049 | 4.11M |
| 310 | CAMP | Camp4 Therapeutics Corporation | 173.93M | -6.08% | 44,504 | 3.80M |
| 311 | ARCT | Arcturus Therapeutics Holdings Inc. | 171.61M | -8.76% | 1,036,111 | 97.60M |
| 312 | CRBU | Caribou Biosciences, Inc. | 170.11M | -2.67% | 924,084 | 9.30M |
| 313 | IPHA | Innate Pharma S.A. | 169.06M | -0.56% | 13,947 | 14.84M |
| 314 | VOR | Vor Biopharma Inc. | 159.61M | -14.25% | 794,420 | - |
| 315 | MOLN | Molecular Partners AG | 158.14M | 1.70% | 1,190 | 856.30K |
| 316 | NVCT | Nuvectis Pharma, Inc. | 152.92M | -1.32% | 122,074 | - |
| 317 | CGEN | Compugen Ltd. | 149.66M | -1.23% | 308,880 | 6.90M |
| 318 | CDXS | Codexis, Inc. | 146.33M | -1.22% | 908,382 | 52.93M |
| 319 | ANIX | Anixa Biosciences, Inc. | 143.19M | 6.10% | 153,424 | - |
| 320 | AGEN | Agenus Inc. | 142.84M | -0.71% | 267,946 | 106.83M |
| 321 | PLX | Protalix BioTherapeutics, Inc. | 142.35M | -5.85% | 486,780 | 61.84M |
| 322 | IMMX | Immix Biopharma, Inc. | 142.03M | -0.47% | 644,041 | - |
| 323 | ELTX | Elicio Therapeutics, Inc. | 141.55M | -5.48% | 176,403 | - |
| 324 | CHRS | Coherus Oncology, Inc. | 140.21M | -4.13% | 622,801 | 277.73M |
| 325 | MRSN | Mersana Therapeutics, Inc. | 137.79M | 0.25% | 89,390 | 33.18M |
| 326 | PRLD | Prelude Therapeutics Incorporated | 137.60M | -0.60% | 248,090 | 10.50M |
| 327 | ACTU | Actuate Therapeutics, Inc. | 135.97M | -4.10% | 19,059 | - |
| 328 | CRDF | Cardiff Oncology, Inc. | 134.72M | -1.96% | 829,963 | 501.00K |
| 329 | SPRO | Spero Therapeutics, Inc. | 134.09M | -3.64% | 512,698 | 40.55M |
| 330 | EXOZ | eXoZymes, Inc. | 133.36M | 9.50% | 1,366 | -700.00 |
| 331 | ALEC | Alector, Inc. | 133.16M | -3.94% | 1,528,659 | 69.05M |
| 332 | SAVA | Cassava Sciences, Inc. | 132.85M | -1.43% | 652,166 | - |
| 333 | SGMO | Sangamo Therapeutics, Inc. | 131.94M | -6.93% | 6,340,737 | 32.88M |
| 334 | NTHI | NeOnc Technologies Holdings, Inc. | 128.94M | -4.67% | 46,842 | 59.99K |
| 335 | IRD | Opus Genetics, Inc. | 128.27M | -1.06% | 460,300 | 14.63M |
| 336 | NKTX | Nkarta, Inc. | 127.14M | -1.10% | 639,198 | - |
| 337 | NBY | NovaBay Pharmaceuticals, Inc. | 126.01M | -7.41% | 141,656 | 10.30M |
| 338 | CLYM | Climb Bio, Inc. | 125.46M | -3.66% | 228,226 | - |
| 339 | KLRS | Kalaris Therapeutics, Inc. | 124.93M | 3.57% | 470,108 | - |
| 340 | CNTX | Context Therapeutics Inc. | 124.70M | 8.33% | 214,411 | - |
| 341 | STTK | Shattuck Labs, Inc. | 124.03M | -2.49% | 81,015 | 1.00M |
| 342 | ACOG | Alpha Cognition Inc. | 123.74M | -4.98% | 36,844 | 7.43M |
| 343 | CGTX | Cognition Therapeutics, Inc. | 122.70M | -8.55% | 1,628,567 | - |
| 344 | INO | Inovio Pharmaceuticals, Inc. | 122.29M | -5.82% | 1,573,106 | 182.34K |
| 345 | COYA | Coya Therapeutics, Inc. | 121.15M | -6.01% | 405,353 | 3.99M |
| 346 | FATE | Fate Therapeutics, Inc. | 121.12M | 2.94% | 1,538,535 | 7.14M |
| 347 | ENTX | Entera Bio Ltd. | 121.01M | 1.92% | 21,241 | 124.00K |
| 348 | UNCY | Unicycive Therapeutics, Inc. | 118.85M | -6.59% | 428,191 | - |
| 349 | SPRB | Spruce Biosciences, Inc. | 118.81M | -3.48% | 338,456 | 697.00K |
| 350 | IKT | Inhibikase Therapeutics, Inc. | 118.03M | -1.88% | 41,535 | 1.00 |
| 351 | ELDN | Eledon Pharmaceuticals, Inc. | 116.48M | 0.65% | 4,576,672 | - |
| 352 | DTIL | Precision BioSciences, Inc. | 116.03M | -7.66% | 388,347 | 698.00K |
| 353 | SRZN | Surrozen, Inc. | 115.71M | 4.25% | 38,683 | 3.60M |
| 354 | GLSI | Greenwich LifeSciences, Inc. | 112.64M | -1.33% | 40,968 | - |
| 355 | SEER | Seer, Inc. | 111.58M | 1.01% | 422,379 | 16.38M |
| 356 | ONCY | Oncolytics Biotech Inc. | 110.39M | 0.97% | 814,662 | - |
| 357 | QNCX | Quince Therapeutics, Inc. | 107.47M | 1.05% | 702,454 | - |
| 358 | KPTI | Karyopharm Therapeutics Inc. | 101.96M | -4.17% | 220,267 | 142.53M |
| 359 | SLGL | Sol-Gel Technologies Ltd. | 100.40M | 1.81% | 14,499 | 23.93M |
| 360 | VANI | Vivani Medical, Inc. | 99.94M | -2.84% | 169,846 | - |
| 361 | ORMP | Oramed Pharmaceuticals Inc. | 99.31M | 0.20% | 353,570 | 2.00M |
| 362 | GANX | Gain Therapeutics, Inc. | 99.27M | -3.51% | 539,755 | - |
| 363 | ATRA | Atara Biotherapeutics, Inc. | 99.07M | 2.08% | 39,547 | 151.93M |
| 364 | ATOS | Atossa Therapeutics, Inc. | 98.64M | -3.34% | 453,423 | - |
| 365 | WHWK | Whitehawk Therapeutics, Inc. | 98.50M | -2.34% | 175,519 | 14.38M |
| 366 | ZNTL | Zentalis Pharmaceuticals, Inc. | 96.09M | -2.21% | 360,130 | 26.87M |
| 367 | ANEB | Anebulo Pharmaceuticals, Inc. | 94.49M | -1.29% | 8,601 | - |
| 368 | CSBR | Champions Oncology, Inc. | 94.45M | - | 7,377 | 56.88M |
| 369 | ABOS | Acumen Pharmaceuticals, Inc. | 93.89M | -6.63% | 132,709 | - |
| 370 | ADVM | Adverum Biotechnologies, Inc. | 93.83M | - | 230,415 | 1.00M |
| 371 | ACET | Adicet Bio, Inc. | 93.33M | -3.99% | 1,476,914 | - |
| 372 | VXRT | Vaxart, Inc. | 93.19M | -1.32% | 359,584 | 148.20M |
| 373 | RPTX | Repare Therapeutics Inc. | 92.36M | -3.59% | 1,399,917 | 11.87M |
| 374 | PLRX | Pliant Therapeutics, Inc. | 92.17M | -4.46% | 1,266,032 | - |
| 375 | PTHS | Pelthos Therapeutics Inc. | 91.88M | -5.72% | 37,955 | 7.41M |
| 376 | OVID | Ovid Therapeutics Inc. | 91.15M | -3.03% | 691,729 | 6.61M |
| 377 | MGNX | MacroGenics, Inc. | 89.83M | -7.79% | 738,157 | 127.63M |
| 378 | HURA | TuHURA Biosciences, Inc. | 89.70M | -9.33% | 251,759 | - |
| 379 | ANVS | Annovis Bio, Inc. | 89.58M | 0.30% | 2,411,716 | - |
| 380 | TVGN | Tevogen Bio Holdings Inc. | 89.29M | 9.85% | 340,462 | - |
| 381 | THAR | Tharimmune, Inc. | 87.26M | -5.68% | 367,719 | - |
| 382 | OTLK | Outlook Therapeutics, Inc. | 87.06M | 2.62% | 3,334,740 | 1.51M |
| 383 | IMUX | Immunic, Inc. | 85.80M | -6.14% | 1,032,272 | - |
| 384 | IFRX | InflaRx N.V. | 85.36M | -0.79% | 1,064,704 | 73.73K |
| 385 | ADAG | Adagene Inc. | 85.31M | -8.72% | 36,821 | 103.20K |
| 386 | HYFT | MindWalk Holdings Corp. | 83.54M | 2.84% | 574,590 | 18.21M |
| 387 | ARTV | Artiva Biotherapeutics, Inc. | 83.21M | -12.85% | 165,116 | 251.00K |
| 388 | TIL | Instil Bio, Inc. | 82.74M | -6.15% | 49,450 | - |
| 389 | CRVO | CervoMed Inc. | 79.71M | 3.80% | 136,298 | 6.16M |
| 390 | ALXO | ALX Oncology Holdings Inc. | 79.70M | -9.82% | 286,894 | - |
| 391 | TTRX | Turn Therapeutics Inc. | 79.30M | -4.71% | 237,397 | - |
| 392 | BYSI | BeyondSpring Inc. | 78.65M | - | 16,155 | 1.88M |
| 393 | IMA | ImageneBio, Inc. | 78.07M | -3.93% | 44,811 | 800.00K |
| 394 | BMEA | Biomea Fusion, Inc. | 77.77M | -6.78% | 1,417,768 | - |
| 395 | STRO | Sutro Biopharma, Inc. | 77.47M | 2.25% | 588,830 | 105.65M |
| 396 | FBIO | Fortress Biotech, Inc. | 77.36M | -2.62% | 324,683 | 62.30M |
| 397 | COEP | Coeptis Therapeutics Holdings, Inc. | 76.93M | -6.12% | 34,401 | 501.00K |
| 398 | OKYO | OKYO Pharma Limited | 75.97M | -5.16% | 130,630 | - |
| 399 | ACRV | Acrivon Therapeutics, Inc. | 74.24M | -2.88% | 291,188 | - |
| 400 | PMVP | PMV Pharmaceuticals, Inc. | 72.37M | -2.86% | 179,803 | - |
| 401 | MNOV | MediciNova, Inc. | 70.14M | -0.69% | 75,952 | 257.92K |
| 402 | CBUS | Cibus, Inc. | 68.94M | -2.31% | 181,001 | 3.79M |
| 403 | BCAB | BioAtla, Inc. | 68.20M | -4.92% | 4,840,863 | 11.00M |
| 404 | PSTV | Plus Therapeutics, Inc. | 67.35M | -3.92% | 2,839,459 | 5.26M |
| 405 | ATYR | aTyr Pharma, Inc. | 66.16M | -3.68% | 4,583,725 | 190.00K |
| 406 | ESLA | Estrella Immunopharma, Inc. | 66.09M | -3.85% | 189,541 | - |
| 407 | XBIT | XBiotech Inc. | 65.85M | -8.09% | 71,535 | - |
| 408 | LITS | Lite Strategy, Inc. | 65.48M | -7.77% | 905,590 | - |
| 409 | ABVC | ABVC BioPharma, Inc. | 64.11M | -6.85% | 68,155 | 797.92K |
| 410 | ATHE | Alterity Therapeutics Limited | 63.25M | 0.83% | 7,394 | 3.57M |
| 411 | NTRB | Nutriband Inc. | 62.12M | 1.17% | 9,951 | 2.58M |
| 412 | EQ | Equillium, Inc. | 61.50M | 1.00% | 162,074 | 4.39M |
| 413 | MGX | Metagenomi, Inc. | 60.45M | -5.29% | 298,710 | 30.91M |
| 414 | KRRO | Korro Bio, Inc. | 60.36M | 3.05% | 562,404 | 7.37M |
| 415 | PYPD | PolyPid Ltd. | 60.05M | -0.82% | 60,477 | - |
| 416 | TCRX | TScan Therapeutics, Inc. | 58.45M | 4.03% | 927,193 | 8.42M |
| 417 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 57.31M | -6.32% | 2,792,729 | - |
| 418 | OSTX | OS Therapies Incorporated | 55.33M | -4.62% | 236,427 | - |
| 419 | ANL | Adlai Nortye Ltd. | 53.87M | -7.01% | 7,476 | 1.94M |
| 420 | JSPR | Jasper Therapeutics, Inc. | 51.77M | 1.09% | 283,922 | - |
| 421 | ALGS | Aligos Therapeutics, Inc. | 50.64M | 3.91% | 92,251 | 2.65M |
| 422 | NRXP | NRx Pharmaceuticals, Inc. | 50.63M | -6.58% | 500,143 | 242.00K |
| 423 | INKT | MiNK Therapeutics, Inc. | 49.84M | -2.56% | 13,063 | - |
| 424 | CVM | CEL-SCI Corporation | 49.72M | -7.03% | 75,190 | - |
| 425 | IOBT | IO Biotech, Inc. | 49.52M | -8.90% | 348,736 | - |
| 426 | TELO | Telomir Pharmaceuticals, Inc. | 49.16M | - | 163,045 | - |
| 427 | LVTX | LAVA Therapeutics N.V. | 47.61M | 1.69% | 327,313 | 4.99M |
| 428 | SNTI | Senti Biosciences, Inc. | 46.27M | 2.92% | 114,348 | - |
| 429 | IBO | Impact BioMedical Inc. | 45.94M | -0.45% | 129,279 | 25.00K |
| 430 | CUE | Cue Biopharma, Inc. | 45.68M | 0.03% | 130,170 | 7.10M |
| 431 | JUNS | Jupiter Neurosciences, Inc. | 45.63M | 4.80% | 46,105 | - |
| 432 | CALC | CalciMedica, Inc. | 45.48M | 2.80% | 83,789 | - |
| 433 | KZR | Kezar Life Sciences, Inc. | 45.40M | -0.16% | 14,874 | - |
| 434 | IPSC | Century Therapeutics, Inc. | 45.13M | 5.49% | 885,739 | 113.34M |
| 435 | CELU | Celularity Inc. | 45.11M | -2.87% | 25,410 | 40.58M |
| 436 | HOWL | Werewolf Therapeutics, Inc. | 44.89M | 1.04% | 446,411 | 1.14M |
| 437 | GRCE | Grace Therapeutics, Inc. | 44.08M | -1.27% | 69,343 | - |
| 438 | ATNM | Actinium Pharmaceuticals, Inc. | 42.43M | -4.90% | 123,256 | 90.00K |
| 439 | XLO | Xilio Therapeutics, Inc. | 42.37M | 7.60% | 589,020 | 31.80M |
| 440 | VRCA | Verrica Pharmaceuticals Inc. | 42.32M | 16.97% | 275,478 | 30.83M |
| 441 | ICCC | ImmuCell Corporation | 42.24M | 2.41% | 15,126 | 27.77M |
| 442 | SKYE | Skye Bioscience, Inc. | 42.00M | -1.50% | 133,495 | - |
| 443 | GNTA | Genenta Science S.p.A. | 41.47M | -11.06% | 115,828 | - |
| 444 | SER | Serina Therapeutics, Inc. | 41.21M | 2.77% | 25,589 | 116.00K |
| 445 | APLT | Applied Therapeutics, Inc. | 41.13M | -4.49% | 16,088,048 | 1.00M |
| 446 | EVAX | Evaxion A/S | 40.52M | -7.22% | 135,236 | 7.65M |
| 447 | INMB | INmune Bio, Inc. | 40.14M | 0.67% | 227,753 | 50.00K |
| 448 | SABS | SAB Biotherapeutics, Inc. | 39.87M | -2.05% | 224,593 | 114.70K |
| 449 | PDSB | PDS Biotechnology Corporation | 39.57M | -4.93% | 503,808 | - |
| 450 | RADX | Radiopharm Theranostics Limited | 39.53M | 7.44% | 7,134 | 8.20M |
| 451 | APLM | Apollomics, Inc. | 38.37M | -2.51% | 7,284 | 198.00K |
| 452 | VERU | Veru Inc. | 38.36M | -5.53% | 184,816 | 16.89M |
| 453 | BTAI | BioXcel Therapeutics, Inc. | 38.05M | -5.43% | 547,798 | 752.00K |
| 454 | OKUR | OnKure Therapeutics, Inc. | 37.39M | -5.80% | 63,576 | - |
| 455 | TVRD | Tvardi Therapeutics, Inc. | 36.87M | -4.61% | 59,390 | - |
| 456 | LTRN | Lantern Pharma Inc. | 36.57M | 1.87% | 58,687 | - |
| 457 | MURA | Mural Oncology plc | 36.04M | -0.95% | 99,277 | - |
| 458 | FGEN | FibroGen, Inc. | 34.91M | 0.35% | 26,571 | 8.30M |
| 459 | GBIO | Generation Bio Co. | 34.90M | -1.33% | 33,054 | 15.27M |
| 460 | LNAI | Lunai Bioworks Inc. | 34.77M | 29.31% | 1,486,921 | - |
| 461 | MAIA | MAIA Biotechnology, Inc. | 34.07M | -8.91% | 239,558 | - |
| 462 | HYPD | Hyperion DeFi, Inc. | 33.88M | -4.83% | 319,650 | 345.32K |
| 463 | DYAI | Dyadic International, Inc. | 33.59M | 2.92% | 160,977 | 3.34M |
| 464 | KLTO | Klotho Neurosciences, Inc. | 32.95M | -3.67% | 378,724 | - |
| 465 | NXTC | NextCure, Inc. | 31.71M | -6.40% | 10,201 | - |
| 466 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 30.79M | -7.77% | 644,831 | 1.00M |
| 467 | LIMN | Liminatus Pharma, Inc. | 30.31M | 0.90% | 92,024 | - |
| 468 | XCUR | Exicure, Inc. | 30.21M | 27.11% | 64,246 | 500.00K |
| 469 | NERV | Minerva Neurosciences, Inc. | 30.07M | - | 40,991 | - |
| 470 | IGC | IGC Pharma, Inc. | 29.98M | -2.69% | 366,308 | 1.11M |
| 471 | BRNS | Barinthus Biotherapeutics plc | 29.81M | 2.37% | 77,471 | 14.97M |
| 472 | ANTX | AN2 Therapeutics, Inc. | 29.59M | -3.57% | 23,175 | - |
| 473 | RNTX | Rein Therapeutics Inc. | 29.36M | 3.28% | 139,074 | - |
| 474 | PLUR | Pluri Inc. | 29.08M | -2.38% | 22,729 | 1.33M |
| 475 | NNVC | NanoViricides, Inc. | 27.36M | 2.17% | 449,342 | - |
| 476 | NRSN | NeuroSense Therapeutics Ltd. | 27.30M | -12.10% | 490,890 | - |
| 477 | CLGN | CollPlant Biotechnologies Ltd. | 27.21M | -0.47% | 25,861 | 2.40M |
| 478 | NRXS | NeurAxis, Inc. | 27.06M | 5.83% | 112,086 | 3.36M |
| 479 | GLTO | Galecto, Inc. | 26.98M | -2.59% | 283,917 | - |
| 480 | RNXT | RenovoRx, Inc. | 26.85M | -6.38% | 199,505 | 928.00K |
| 481 | RLYB | Rallybio Corporation | 26.37M | -0.35% | 93,073 | 674.00K |
| 482 | QTTB | Q32 Bio Inc. | 26.09M | -7.02% | 56,194 | - |
| 483 | BOLD | Boundless Bio, Inc. | 25.74M | -3.36% | 90,672 | - |
| 484 | INTS | Intensity Therapeutics, Inc. | 25.67M | -0.60% | 1,116,927 | - |
| 485 | PASG | Passage Bio, Inc. | 25.05M | -7.51% | 58,671 | - |
| 486 | LIXT | Lixte Biotechnology Holdings, Inc. | 24.70M | -0.23% | 70,051 | - |
| 487 | IBIO | iBio, Inc. | 24.51M | -9.92% | 1,220,366 | 500.00K |
| 488 | LEXX | Lexaria Bioscience Corp. | 24.46M | 4.76% | 228,487 | 615.92K |
| 489 | DARE | Daré Bioscience, Inc. | 24.43M | -3.93% | 222,774 | -57.13K |
| 490 | QNTM | Quantum BioPharma Ltd. | 23.91M | -7.07% | 94,181 | - |
| 491 | CVKD | Cadrenal Therapeutics, Inc. | 23.37M | -5.61% | 14,458 | - |
| 492 | ENLV | Enlivex Therapeutics Ltd. | 22.80M | -4.07% | 177,600 | - |
| 493 | PTN | Palatin Technologies, Inc. | 22.39M | 1.77% | 43,211 | 8.85M |
| 494 | PMN | ProMIS Neurosciences, Inc. | 22.35M | 14.38% | 1,821,869 | - |
| 495 | MBRX | Moleculin Biotech, Inc. | 22.31M | 4.33% | 837,128 | - |
| 496 | TPST | Tempest Therapeutics, Inc. | 21.09M | -48.59% | 957,571 | - |
| 497 | GDTC | CytoMed Therapeutics Limited | 20.89M | -8.12% | 63,454 | 573.19K |
| 498 | APVO | Aptevo Therapeutics Inc. | 20.56M | -7.58% | 672,289 | - |
| 499 | CING | Cingulate Inc. | 19.17M | 1.18% | 44,848 | - |
| 500 | SYBX | Synlogic, Inc. | 18.95M | -1.82% | 4,245 | 8.00K |
| 501 | ATHA | Athira Pharma, Inc. | 18.77M | 3.48% | 54,503 | - |
| 502 | CASI | CASI Pharmaceuticals, Inc. | 18.59M | -0.83% | 15,533 | 26.85M |
| 503 | MTVA | MetaVia Inc. | 18.50M | -6.04% | 200,438 | - |
| 504 | ITRM | Iterum Therapeutics plc | 18.50M | -2.75% | 802,118 | 390.00K |
| 505 | CTXR | Citius Pharmaceuticals, Inc. | 18.47M | -6.54% | 203,080 | - |
| 506 | MRKR | Marker Therapeutics, Inc. | 18.17M | 7.92% | 580,133 | 4.69M |
| 507 | LSTA | Lisata Therapeutics, Inc. | 17.91M | -0.98% | 35,627 | 1.07M |
| 508 | HOTH | Hoth Therapeutics, Inc. | 17.84M | -2.54% | 134,712 | - |
| 509 | AKTX | Akari Therapeutics, Plc | 17.82M | -6.01% | 94,762 | - |
| 510 | LPCN | Lipocine Inc. | 17.82M | -5.03% | 69,159 | 4.32M |
| 511 | FBLG | FibroBiologics, Inc. | 17.73M | 4.30% | 2,891,250 | - |
| 512 | TRAW | Traws Pharma, Inc. | 16.86M | -0.94% | 83,368 | 2.85M |
| 513 | ABP | Abpro Holdings, Inc. | 16.40M | 0.16% | 23,622 | 183.00K |
| 514 | PULM | Pulmatrix, Inc. | 16.00M | -2.67% | 5,197 | 3.00K |
| 515 | PCSA | Processa Pharmaceuticals, Inc. | 15.78M | -8.95% | 1,749,739 | - |
| 516 | CANF | Can-Fite BioPharma Ltd. | 15.62M | -12.92% | 12,165,198 | 560.00K |
| 517 | ALLR | Allarity Therapeutics, Inc. | 15.54M | -6.14% | 351,282 | - |
| 518 | QNRX | Quoin Pharmaceuticals, Ltd. | 15.25M | -5.51% | 130,467 | - |
| 519 | NCEL | NewcelX Ltd. | 15.09M | -2.65% | 24,519 | - |
| 520 | CLSD | Clearside Biomedical, Inc. | 14.97M | -6.84% | 62,448 | 3.33M |
| 521 | KAPA | Kairos Pharma, Ltd. | 14.81M | -4.83% | 131,090 | - |
| 522 | CRIS | Curis, Inc. | 14.61M | -8.13% | 135,904 | 11.65M |
| 523 | BLRX | BioLineRx Ltd. | 14.33M | 3.74% | 42,047 | 17.25M |
| 524 | KZIA | Kazia Therapeutics Limited | 14.20M | 34.38% | 27,121,062 | 1.20M |
| 525 | BCDA | BioCardia, Inc. | 14.01M | 2.33% | 39,576 | 3.00K |
| 526 | CMMB | Chemomab Therapeutics Ltd. | 13.97M | -1.10% | 92,558 | - |
| 527 | DWTX | Dogwood Therapeutics, Inc. | 13.69M | -2.93% | 37,024 | - |
| 528 | BCTX | BriaCell Therapeutics Corp. | 13.55M | -8.19% | 47,445 | - |
| 529 | PHIO | Phio Pharmaceuticals Corp. | 13.46M | -1.57% | 558,832 | - |
| 530 | SNGX | Soligenix, Inc. | 13.31M | -3.65% | 557,633 | 2.34K |
| 531 | APM | Aptorum Group Limited | 13.19M | 3.85% | 256,357 | - |
| 532 | LGVN | Longeveron Inc. | 13.11M | -3.97% | 544,296 | 1.44M |
| 533 | COCP | Cocrystal Pharma, Inc. | 12.91M | -2.93% | 46,315 | - |
| 534 | BRTX | BioRestorative Therapies, Inc. | 12.69M | 15.32% | 334,923 | 383.40K |
| 535 | SNSE | Sensei Biotherapeutics, Inc. | 12.63M | 17.27% | 105,157 | - |
| 536 | OSRH | OSR Holdings, Inc. | 12.62M | -1.88% | 131,572 | -90.52K |
| 537 | GOVX | GeoVax Labs, Inc. | 12.32M | 1.67% | 335,516 | 3.35M |
| 538 | EDSA | Edesa Biotech, Inc. | 12.18M | -0.57% | 12,408 | - |
| 539 | CLRB | Cellectar Biosciences, Inc. | 12.13M | -6.84% | 48,976 | - |
| 540 | VYNE | VYNE Therapeutics Inc. | 11.99M | -5.38% | 617,526 | 524.00K |
| 541 | IMNN | Imunon, Inc. | 11.61M | -7.58% | 39,673 | - |
| 542 | ICU | SeaStar Medical Holding Corporation | 11.22M | -7.13% | 791,912 | 881.00K |
| 543 | IMRN | Immuron Limited | 11.13M | -1.92% | 45,925 | 4.78M |
| 544 | PPCB | Propanc Biopharma, Inc. | 11.01M | 4.87% | 39,664 | - |
| 545 | AEON | AEON Biopharma, Inc. | 10.95M | -2.14% | 168,726 | - |
| 546 | ERNA | Ernexa Therapeutics Inc. | 10.91M | -6.08% | 50,724 | 1,000.00 |
| 547 | CELZ | Creative Medical Technology Holdings, Inc. | 10.76M | -4.59% | 142,945 | 6.00K |
| 548 | ADXN | Addex Therapeutics Ltd | 10.45M | -5.47% | - | 210.35K |
| 549 | NEUP | Neuphoria Therapeutics Inc. | 10.42M | -6.75% | 105,172 | 15.65M |
| 550 | BIVI | BioVie Inc. | 10.33M | -4.20% | 85,719 | - |
| 551 | EVGN | Evogene Ltd. | 10.31M | - | 74,893 | 9.44M |
| 552 | BOLT | Bolt Biotherapeutics, Inc. | 8.98M | 1.41% | 24,922 | 5.20M |
| 553 | ALZN | Alzamend Neuro, Inc. | 8.78M | -5.33% | 729,966 | - |
| 554 | MBIO | Mustang Bio, Inc. | 8.76M | -2.44% | 132,275 | - |
| 555 | ACXP | Acurx Pharmaceuticals, Inc. | 8.34M | -7.83% | 54,053 | - |
| 556 | XTLB | XTL Biopharmaceuticals Ltd. | 8.33M | -4.33% | 22,304 | 451.00K |
| 557 | PLRZ | Polyrizon Ltd. | 8.31M | -6.70% | 99,349 | - |
| 558 | TOVX | Theriva Biologics, Inc. | 7.77M | -8.10% | 2,113,789 | - |
| 559 | ADIL | Adial Pharmaceuticals, Inc. | 7.60M | 2.00% | 215,617 | - |
| 560 | APRE | Aprea Therapeutics, Inc. | 7.57M | 0.84% | 44,218 | 488.24K |
| 561 | INAB | IN8bio, Inc. | 7.51M | -1.22% | 34,912 | - |
| 562 | RNAZ | TransCode Therapeutics, Inc. | 7.49M | -0.44% | 10,183 | - |
| 563 | TCRT | Alaunos Therapeutics, Inc. | 7.39M | -0.90% | 31,607 | 6.00K |
| 564 | PHGE | BiomX Inc. | 7.12M | -5.20% | 1,145,741 | - |
| 565 | KPRX | Kiora Pharmaceuticals, Inc. | 7.04M | -7.25% | 51,707 | 20.00K |
| 566 | PPBT | Purple Biotech Ltd | 6.61M | -4.67% | 169,490 | - |
| 567 | ENSC | Ensysce Biosciences, Inc. | 6.48M | -5.18% | 99,739 | 4.49M |
| 568 | NCNA | NuCana plc | 6.39M | 1.21% | 33,643 | - |
| 569 | LYRA | Lyra Therapeutics, Inc. | 6.16M | -4.93% | 14,008 | 600.00K |
| 570 | XBIO | Xenetic Biosciences, Inc. | 5.82M | -1.17% | 209,136 | 2.86M |
| 571 | CLDI | Calidi Biotherapeutics, Inc. | 5.80M | -3.36% | 175,198 | - |
| 572 | VIVS | VivoSim Labs, Inc. | 5.58M | -4.46% | 12,435 | 140.00K |
| 573 | CYCN | Cyclerion Therapeutics, Inc. | 5.37M | -0.70% | 32,982 | 2.86M |
| 574 | SILO | Silo Pharma, Inc. | 5.26M | -5.73% | 108,751 | 72.10K |
| 575 | PBM | Psyence Biomedical Ltd. | 5.22M | - | 9,133 | - |
| 576 | MTNB | Matinas BioPharma Holdings, Inc. | 5.18M | -31.52% | 56,258 | - |
| 577 | GLMD | Galmed Pharmaceuticals Ltd. | 5.16M | -13.56% | 1,334,270 | - |
| 578 | REVB | Revelation Biosciences, Inc. | 5.06M | -0.72% | 120,588 | - |
| 579 | JAGX | Jaguar Health, Inc. | 5.04M | -18.67% | 209,021 | 11.79M |
| 580 | ASBP | Aspire Biopharma Holdings, Inc. | 4.91M | -6.15% | 30,597,053 | 1.94K |
| 581 | ENTO | Entero Therapeutics, Inc. | 4.89M | -19.88% | 461,034 | - |
| 582 | PMCB | PharmaCyte Biotech, Inc. | 4.85M | -5.18% | 15,324 | - |
| 583 | CDIO | Cardio Diagnostics Holdings, Inc. | 4.67M | -6.23% | 79,839 | 15.78K |
| 584 | KALA | KALA BIO, Inc. | 4.44M | -8.10% | 166,409 | - |
| 585 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 4.31M | 1.94% | 40,916 | 1.36M |
| 586 | HCWB | HCW Biologics Inc. | 4.30M | -17.01% | 125,027 | 422.03K |
| 587 | GRI | GRI Bio, Inc. | 4.25M | -5.59% | 222,761 | - |
| 588 | GNPX | Genprex, Inc. | 4.17M | -9.49% | 293,876 | - |
| 589 | OGEN | Oragenics, Inc. | 4.16M | -7.85% | 160,516 | - |
| 590 | SPRC | SciSparc Ltd. | 3.99M | 1.65% | 15,920 | 927.00K |
| 591 | PTIX | Protagenic Therapeutics, Inc. | 3.87M | -8.18% | 69,164 | - |
| 592 | CNSP | CNS Pharmaceuticals, Inc. | 3.87M | - | 3,103 | - |
| 593 | BGMS | Bio Green Med Solution, Inc. | 3.79M | -3.73% | 42,638 | 81.00K |
| 594 | ARTL | Artelo Biosciences, Inc. | 3.73M | -2.12% | 51,368 | - |
| 595 | ONCO | Onconetix, Inc. | 3.73M | -5.50% | 14,553 | 1.22M |
| 596 | ELAB | PMGC Holdings Inc. | 3.70M | 1.74% | 78,961 | -241.53K |
| 597 | KTTA | Pasithea Therapeutics Corp. | 3.54M | -27.89% | 1,072,926 | - |
| 598 | AZTR | Azitra, Inc. | 3.36M | -3.91% | 225,808 | 7.50K |
| 599 | SLRX | Salarius Pharmaceuticals, Inc. | 3.32M | -8.32% | 1,544,048 | - |
| 600 | SCNI | Scinai Immunotherapeutics Ltd. | 3.15M | 1.73% | 15,796 | 1.15M |
| 601 | XRTX | XORTX Therapeutics Inc. | 3.13M | -1.02% | 42,447 | - |
| 602 | ENVB | Enveric Biosciences, Inc. | 3.03M | 3.00% | 55,044 | - |
| 603 | GTBP | GT Biopharma, Inc. | 2.42M | 3.74% | 823,739 | - |
| 604 | BDRX | Biodexa Pharmaceuticals Plc | 2.39M | -16.09% | 93,683 | 104.90K |
| 605 | INDP | Indaptus Therapeutics, Inc. | 2.29M | -10.39% | 68,167 | - |
| 606 | MLEC | Moolec Science SA | 2.26M | 1.02% | 58,938 | 7.83M |
| 607 | VRAX | Virax Biolabs Group Limited | 1.91M | -2.33% | 28,464 | 6.33K |
| 608 | DRMA | Dermata Therapeutics, Inc. | 1.66M | -8.61% | 158,770 | - |
| 609 | SLXN | Silexion Therapeutics Corp | 1.39M | -3.89% | 42,687 | - |
| 610 | CMND | Clearmind Medicine Inc. | 1.11M | -6.42% | 11,758,525 | - |
| 611 | CDT | CDT Equity Inc. | 665.99K | -16.75% | 113,846 | - |
| 612 | ADTX | Aditxt, Inc. | 153.26K | -14.71% | 170,659 | 5.95K |